The CHMP has advised against EU approval of Eli Lilly's Alzheimer's drug Kisunla, potentially handing an advantage to Eisai/Biogen's rival drug.

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava in a sign of its ambition to build its European operations, including the supply of weight-loss medicines.